Armata Pharmaceuticals Inc
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudo… Read more
Armata Pharmaceuticals Inc (ARMP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.045x
Based on the latest financial reports, Armata Pharmaceuticals Inc (ARMP) has a cash flow conversion efficiency ratio of 0.045x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.30 Million) by net assets ($-95.59 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Armata Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (1993–2024)
This chart illustrates how Armata Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Armata Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Armata Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hillgrove Resources Limited
PINK:HLGVF
|
0.205x |
|
Hitron Technologies Inc
TW:2419
|
-0.018x |
|
Beacon Lighting Group Ltd
AU:BLX
|
0.172x |
|
Unic Technology
TWO:5452
|
0.021x |
|
Power Wind Health Industry Incorporated
TW:8462
|
0.239x |
|
Medallion Metals Ltd
AU:MM8
|
-0.155x |
|
Trimegah Securities Tbk
JK:TRIM
|
-0.199x |
|
Magellan Aerospace Corporation
PINK:MALJF
|
0.006x |
Annual Cash Flow Conversion Efficiency for Armata Pharmaceuticals Inc (1993–2024)
The table below shows the annual cash flow conversion efficiency of Armata Pharmaceuticals Inc from 1993 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-48.02 Million | $-37.55 Million | 0.782x | -47.12% |
| 2023-12-31 | $-32.06 Million | $-47.42 Million | 1.479x | +264.28% |
| 2022-12-31 | $36.08 Million | $-32.48 Million | -0.900x | +3.02% |
| 2021-12-31 | $25.40 Million | $-23.57 Million | -0.928x | +4.19% |
| 2020-12-31 | $18.86 Million | $-18.27 Million | -0.969x | +9.26% |
| 2019-12-31 | $14.59 Million | $-15.58 Million | -1.068x | +3.56% |
| 2018-12-31 | $8.47 Million | $-9.38 Million | -1.107x | +6.88% |
| 2017-12-31 | $7.73 Million | $-9.19 Million | -1.189x | -9.17% |
| 2016-12-31 | $9.72 Million | $-10.59 Million | -1.089x | -41.56% |
| 2015-12-31 | $12.71 Million | $-9.78 Million | -0.769x | +78.97% |
| 2014-12-31 | $3.44 Million | $-12.57 Million | -3.658x | -798.42% |
| 2013-12-31 | $-14.22 Million | $-7.45 Million | 0.524x | +258.34% |
| 2012-12-31 | $12.94 Million | $-4.28 Million | -0.331x | +49.36% |
| 2011-12-31 | $7.15 Million | $-4.67 Million | -0.653x | -123.91% |
| 2008-12-31 | $-3.77 Million | $-10.30 Million | 2.732x | +419.60% |
| 2007-12-31 | $16.24 Million | $-13.88 Million | -0.855x | +60.57% |
| 2006-12-31 | $5.37 Million | $-11.64 Million | -2.168x | -304.37% |
| 2005-12-31 | $30.57 Million | $-16.39 Million | -0.536x | -71.88% |
| 2004-12-31 | $49.76 Million | $-15.52 Million | -0.312x | +4.92% |
| 2003-12-31 | $34.23 Million | $-11.23 Million | -0.328x | +89.15% |
| 2002-12-31 | $6.65 Million | $-20.10 Million | -3.024x | -380.36% |
| 2001-12-31 | $37.40 Million | $-23.54 Million | -0.629x | -6493.84% |
| 2000-12-31 | $63.43 Million | $-605.54K | -0.010x | +99.37% |
| 1999-12-31 | $7.00 Million | $-10.60 Million | -1.514x | -213.30% |
| 1998-12-31 | $12.00 Million | $-5.80 Million | -0.483x | +78.35% |
| 1997-12-31 | $5.60 Million | $-12.50 Million | -2.232x | -318.53% |
| 1996-12-31 | $19.50 Million | $-10.40 Million | -0.533x | +0.86% |
| 1995-12-31 | $15.80 Million | $-8.50 Million | -0.538x | +1.37% |
| 1994-12-31 | $13.20 Million | $-7.20 Million | -0.545x | -26.45% |
| 1993-12-31 | $10.20 Million | $-4.40 Million | -0.431x | -- |